Patent · US Active

Quinazolines as potassium ion channel inhibitors

US8575184B2 · kind B2 · utility

11Cited by

25References

40Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

James A. Johnson · Lawrenceville, US
John Lloyd · Yardley, US
Heather Finlay · Skillman, US
Ji Jiang · Plainsboro, US
James Neels · Newtown, US
Naveen Kumar Dhondi · Secunderabad, IN
Prashantha Gunaga · Savanuru, IN
Abhisek Banerjee · Narayanpur, IN

Key dates

Filing date	Sep 1, 2010
Grant date	Nov 5, 2013
Priority date	—
Expiry date	Sep 1, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula (I) wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.